Accenture Information Governance Framework to Guide E-Health Investments & Strategy
Filed under: Americas, Business, Data Management, Healthcare, IT Services, Technology
RESTON, VA; Aug. 12, 2010 – According to a new report from Accenture (NYSE: ACN), healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance – data privacy, confidentiality, security, quality and integrity.
The report, Information Governance: The Foundation for Effective e-Health, details and explores specific targets for the five disciplines and provides an actionable framework that healthcare organizations, such as care providers, insurers, and public health organizations can use to perform a high-level assessment of their current information management situation, challenges and opportunities. The objective is to ensure investments in e-health are supporting strategic goals of increasing efficiency and reducing costs, reducing errors, and improving patient outcomes. The target areas for evaluation explained in the report are: Read more
Albert Einstein College of Medicine Receives $10.8 mn Grant to Develop Stem Cell based Therapies
Newswise — Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome – part of acute radiation syndrome (ARS) – for military personnel, first responders and the general public. The Einstein research, funded by the federal Centers for Medical Countermeasures Against Radiation, is part of a program coordinated by the National Institute of Allergy and Infectious Diseases.
“This type of research fills a special need,” said lead investigator Chandan Guha, M.B.B.S., Ph.D., professor and vice chair of radiation oncology at Einstein and Montefiore Medical Center. “Currently, post-event strategies for responding to ARS must be carried out within the first several hours of an event, and those strategies have demonstrated only marginal protection.” At present, there are no Food and Drug Administration (FDA)-approved treatments that can effectively treat ARS. For first responders and others, this lack of protection against the effects of radiation could be fatal. Read more